Kyntra Bio, Inc. (KYNB) vs Quantum BioPharma Ltd. (QNTM)
A side-by-side comparison of Kyntra Bio, Inc. and Quantum BioPharma Ltd. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
KYNB
Kyntra Bio, Inc.
$5.92HealthcareDelayed quote: Oct 6, 2026, 2:42 PM EDT
QNTM
Quantum BioPharma Ltd.
$3.21HealthcareDelayed quote: Oct 6, 2026, 2:43 PM EDT
Total return — KYNB vs QNTM
growth of $100 · dividends reinvested · last 8yKYNB -99.6% (-49.4%/yr)QNTM -99.7% (-51.8%/yr)KYNB compounded faster over this window
KYNB QNTM
KYNB vs QNTM: by the numbers
- •KYNB is the larger company ($24M vs $21M market cap).
- •KYNB is profitable (3967.77% net margin) while QNTM runs a net loss (0.00%).
Metrics side by side
Valuation
| Metric | KYNB | QNTM |
|---|---|---|
| P/S ratio | 5.19 | N/A |
| P/B ratio | N/A | 2.59 |
Profitability
| Metric | KYNB | QNTM |
|---|---|---|
| Gross margin | 91.37% | 0.00% |
| Operating margin | -712.66% | 0.00% |
| Net margin | 3967.77% | 0.00% |
| ROE | N/A | -313.46% |
| ROIC | -78.16% | -27.14% |
Growth (annualized)
| Metric | KYNB | QNTM |
|---|---|---|
| Revenue CAGR (5Y) | -51.49% | N/A |
| Total return CAGR (5Y) | -52.67% | -49.16% |
Frequently asked
- Is KYNB or QNTM more profitable?
- KYNB runs the higher net margin — KYNB at 3967.77% versus QNTM at 0.00%.
- How have KYNB and QNTM total returns compared?
- Over the past 5 years, KYNB delivered -52.67% and QNTM delivered -49.16% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.